The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Allergy Non-pharmacologic Therapy Market Research Report 2025
Synopsis
The global Allergy Non-pharmacologic Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Allergy Non-pharmacologic Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allergy Non-pharmacologic Therapy.
Report Scope
The Allergy Non-pharmacologic Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Allergy Non-pharmacologic Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allergy Non-pharmacologic Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Kirkland
GNC
Blackmores
Thompson's
BY-HEALTH
Healthy Care
Emerald Labs
FANCL Corporation
Zahler
VitaTree
Segment by Type
Capsule
Tablet
Liquid
Segment by Application
Skin Allergy
Pouen Allergy
Dust Allergy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Allergy Non-pharmacologic Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Allergy Non-pharmacologic Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Allergy Non-pharmacologic Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allergy Non-pharmacologic Therapy.
Report Scope
The Allergy Non-pharmacologic Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Allergy Non-pharmacologic Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allergy Non-pharmacologic Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Kirkland
GNC
Blackmores
Thompson's
BY-HEALTH
Healthy Care
Emerald Labs
FANCL Corporation
Zahler
VitaTree
Segment by Type
Capsule
Tablet
Liquid
Segment by Application
Skin Allergy
Pouen Allergy
Dust Allergy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Allergy Non-pharmacologic Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Allergy Non-pharmacologic Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Capsule
1.2.3 Tablet
1.2.4 Liquid
1.3 Market by Application
1.3.1 Global Allergy Non-pharmacologic Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Skin Allergy
1.3.3 Pouen Allergy
1.3.4 Dust Allergy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Allergy Non-pharmacologic Therapy Market Perspective (2019-2030)
2.2 Allergy Non-pharmacologic Therapy Growth Trends by Region
2.2.1 Global Allergy Non-pharmacologic Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Allergy Non-pharmacologic Therapy Historic Market Size by Region (2019-2024)
2.2.3 Allergy Non-pharmacologic Therapy Forecasted Market Size by Region (2025-2030)
2.3 Allergy Non-pharmacologic Therapy Market Dynamics
2.3.1 Allergy Non-pharmacologic Therapy Industry Trends
2.3.2 Allergy Non-pharmacologic Therapy Market Drivers
2.3.3 Allergy Non-pharmacologic Therapy Market Challenges
2.3.4 Allergy Non-pharmacologic Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Allergy Non-pharmacologic Therapy Players by Revenue
3.1.1 Global Top Allergy Non-pharmacologic Therapy Players by Revenue (2019-2024)
3.1.2 Global Allergy Non-pharmacologic Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Allergy Non-pharmacologic Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Allergy Non-pharmacologic Therapy Revenue
3.4 Global Allergy Non-pharmacologic Therapy Market Concentration Ratio
3.4.1 Global Allergy Non-pharmacologic Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Allergy Non-pharmacologic Therapy Revenue in 2023
3.5 Allergy Non-pharmacologic Therapy Key Players Head office and Area Served
3.6 Key Players Allergy Non-pharmacologic Therapy Product Solution and Service
3.7 Date of Enter into Allergy Non-pharmacologic Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Allergy Non-pharmacologic Therapy Breakdown Data by Type
4.1 Global Allergy Non-pharmacologic Therapy Historic Market Size by Type (2019-2024)
4.2 Global Allergy Non-pharmacologic Therapy Forecasted Market Size by Type (2025-2030)
5 Allergy Non-pharmacologic Therapy Breakdown Data by Application
5.1 Global Allergy Non-pharmacologic Therapy Historic Market Size by Application (2019-2024)
5.2 Global Allergy Non-pharmacologic Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Allergy Non-pharmacologic Therapy Market Size (2019-2030)
6.2 North America Allergy Non-pharmacologic Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Allergy Non-pharmacologic Therapy Market Size by Country (2019-2024)
6.4 North America Allergy Non-pharmacologic Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Allergy Non-pharmacologic Therapy Market Size (2019-2030)
7.2 Europe Allergy Non-pharmacologic Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Allergy Non-pharmacologic Therapy Market Size by Country (2019-2024)
7.4 Europe Allergy Non-pharmacologic Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Allergy Non-pharmacologic Therapy Market Size (2019-2030)
8.2 Asia-Pacific Allergy Non-pharmacologic Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Allergy Non-pharmacologic Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Allergy Non-pharmacologic Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Allergy Non-pharmacologic Therapy Market Size (2019-2030)
9.2 Latin America Allergy Non-pharmacologic Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Allergy Non-pharmacologic Therapy Market Size by Country (2019-2024)
9.4 Latin America Allergy Non-pharmacologic Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Allergy Non-pharmacologic Therapy Market Size (2019-2030)
10.2 Middle East & Africa Allergy Non-pharmacologic Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Allergy Non-pharmacologic Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Allergy Non-pharmacologic Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Kirkland
11.1.1 Kirkland Company Detail
11.1.2 Kirkland Business Overview
11.1.3 Kirkland Allergy Non-pharmacologic Therapy Introduction
11.1.4 Kirkland Revenue in Allergy Non-pharmacologic Therapy Business (2019-2024)
11.1.5 Kirkland Recent Development
11.2 GNC
11.2.1 GNC Company Detail
11.2.2 GNC Business Overview
11.2.3 GNC Allergy Non-pharmacologic Therapy Introduction
11.2.4 GNC Revenue in Allergy Non-pharmacologic Therapy Business (2019-2024)
11.2.5 GNC Recent Development
11.3 Blackmores
11.3.1 Blackmores Company Detail
11.3.2 Blackmores Business Overview
11.3.3 Blackmores Allergy Non-pharmacologic Therapy Introduction
11.3.4 Blackmores Revenue in Allergy Non-pharmacologic Therapy Business (2019-2024)
11.3.5 Blackmores Recent Development
11.4 Thompson's
11.4.1 Thompson's Company Detail
11.4.2 Thompson's Business Overview
11.4.3 Thompson's Allergy Non-pharmacologic Therapy Introduction
11.4.4 Thompson's Revenue in Allergy Non-pharmacologic Therapy Business (2019-2024)
11.4.5 Thompson's Recent Development
11.5 BY-HEALTH
11.5.1 BY-HEALTH Company Detail
11.5.2 BY-HEALTH Business Overview
11.5.3 BY-HEALTH Allergy Non-pharmacologic Therapy Introduction
11.5.4 BY-HEALTH Revenue in Allergy Non-pharmacologic Therapy Business (2019-2024)
11.5.5 BY-HEALTH Recent Development
11.6 Healthy Care
11.6.1 Healthy Care Company Detail
11.6.2 Healthy Care Business Overview
11.6.3 Healthy Care Allergy Non-pharmacologic Therapy Introduction
11.6.4 Healthy Care Revenue in Allergy Non-pharmacologic Therapy Business (2019-2024)
11.6.5 Healthy Care Recent Development
11.7 Emerald Labs
11.7.1 Emerald Labs Company Detail
11.7.2 Emerald Labs Business Overview
11.7.3 Emerald Labs Allergy Non-pharmacologic Therapy Introduction
11.7.4 Emerald Labs Revenue in Allergy Non-pharmacologic Therapy Business (2019-2024)
11.7.5 Emerald Labs Recent Development
11.8 FANCL Corporation
11.8.1 FANCL Corporation Company Detail
11.8.2 FANCL Corporation Business Overview
11.8.3 FANCL Corporation Allergy Non-pharmacologic Therapy Introduction
11.8.4 FANCL Corporation Revenue in Allergy Non-pharmacologic Therapy Business (2019-2024)
11.8.5 FANCL Corporation Recent Development
11.9 Zahler
11.9.1 Zahler Company Detail
11.9.2 Zahler Business Overview
11.9.3 Zahler Allergy Non-pharmacologic Therapy Introduction
11.9.4 Zahler Revenue in Allergy Non-pharmacologic Therapy Business (2019-2024)
11.9.5 Zahler Recent Development
11.10 VitaTree
11.10.1 VitaTree Company Detail
11.10.2 VitaTree Business Overview
11.10.3 VitaTree Allergy Non-pharmacologic Therapy Introduction
11.10.4 VitaTree Revenue in Allergy Non-pharmacologic Therapy Business (2019-2024)
11.10.5 VitaTree Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Allergy Non-pharmacologic Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Capsule
Table 3. Key Players of Tablet
Table 4. Key Players of Liquid
Table 5. Global Allergy Non-pharmacologic Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Allergy Non-pharmacologic Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Allergy Non-pharmacologic Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Allergy Non-pharmacologic Therapy Market Share by Region (2019-2024)
Table 9. Global Allergy Non-pharmacologic Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Allergy Non-pharmacologic Therapy Market Share by Region (2025-2030)
Table 11. Allergy Non-pharmacologic Therapy Market Trends
Table 12. Allergy Non-pharmacologic Therapy Market Drivers
Table 13. Allergy Non-pharmacologic Therapy Market Challenges
Table 14. Allergy Non-pharmacologic Therapy Market Restraints
Table 15. Global Allergy Non-pharmacologic Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Allergy Non-pharmacologic Therapy Market Share by Players (2019-2024)
Table 17. Global Top Allergy Non-pharmacologic Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergy Non-pharmacologic Therapy as of 2023)
Table 18. Ranking of Global Top Allergy Non-pharmacologic Therapy Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Allergy Non-pharmacologic Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Allergy Non-pharmacologic Therapy Product Solution and Service
Table 22. Date of Enter into Allergy Non-pharmacologic Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Allergy Non-pharmacologic Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Allergy Non-pharmacologic Therapy Revenue Market Share by Type (2019-2024)
Table 26. Global Allergy Non-pharmacologic Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Allergy Non-pharmacologic Therapy Revenue Market Share by Type (2025-2030)
Table 28. Global Allergy Non-pharmacologic Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Allergy Non-pharmacologic Therapy Revenue Market Share by Application (2019-2024)
Table 30. Global Allergy Non-pharmacologic Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Allergy Non-pharmacologic Therapy Revenue Market Share by Application (2025-2030)
Table 32. North America Allergy Non-pharmacologic Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Allergy Non-pharmacologic Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Allergy Non-pharmacologic Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Allergy Non-pharmacologic Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Allergy Non-pharmacologic Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Allergy Non-pharmacologic Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Allergy Non-pharmacologic Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Allergy Non-pharmacologic Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Allergy Non-pharmacologic Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Allergy Non-pharmacologic Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Allergy Non-pharmacologic Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Allergy Non-pharmacologic Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Allergy Non-pharmacologic Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Allergy Non-pharmacologic Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Allergy Non-pharmacologic Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 47. Kirkland Company Detail
Table 48. Kirkland Business Overview
Table 49. Kirkland Allergy Non-pharmacologic Therapy Product
Table 50. Kirkland Revenue in Allergy Non-pharmacologic Therapy Business (2019-2024) & (US$ Million)
Table 51. Kirkland Recent Development
Table 52. GNC Company Detail
Table 53. GNC Business Overview
Table 54. GNC Allergy Non-pharmacologic Therapy Product
Table 55. GNC Revenue in Allergy Non-pharmacologic Therapy Business (2019-2024) & (US$ Million)
Table 56. GNC Recent Development
Table 57. Blackmores Company Detail
Table 58. Blackmores Business Overview
Table 59. Blackmores Allergy Non-pharmacologic Therapy Product
Table 60. Blackmores Revenue in Allergy Non-pharmacologic Therapy Business (2019-2024) & (US$ Million)
Table 61. Blackmores Recent Development
Table 62. Thompson's Company Detail
Table 63. Thompson's Business Overview
Table 64. Thompson's Allergy Non-pharmacologic Therapy Product
Table 65. Thompson's Revenue in Allergy Non-pharmacologic Therapy Business (2019-2024) & (US$ Million)
Table 66. Thompson's Recent Development
Table 67. BY-HEALTH Company Detail
Table 68. BY-HEALTH Business Overview
Table 69. BY-HEALTH Allergy Non-pharmacologic Therapy Product
Table 70. BY-HEALTH Revenue in Allergy Non-pharmacologic Therapy Business (2019-2024) & (US$ Million)
Table 71. BY-HEALTH Recent Development
Table 72. Healthy Care Company Detail
Table 73. Healthy Care Business Overview
Table 74. Healthy Care Allergy Non-pharmacologic Therapy Product
Table 75. Healthy Care Revenue in Allergy Non-pharmacologic Therapy Business (2019-2024) & (US$ Million)
Table 76. Healthy Care Recent Development
Table 77. Emerald Labs Company Detail
Table 78. Emerald Labs Business Overview
Table 79. Emerald Labs Allergy Non-pharmacologic Therapy Product
Table 80. Emerald Labs Revenue in Allergy Non-pharmacologic Therapy Business (2019-2024) & (US$ Million)
Table 81. Emerald Labs Recent Development
Table 82. FANCL Corporation Company Detail
Table 83. FANCL Corporation Business Overview
Table 84. FANCL Corporation Allergy Non-pharmacologic Therapy Product
Table 85. FANCL Corporation Revenue in Allergy Non-pharmacologic Therapy Business (2019-2024) & (US$ Million)
Table 86. FANCL Corporation Recent Development
Table 87. Zahler Company Detail
Table 88. Zahler Business Overview
Table 89. Zahler Allergy Non-pharmacologic Therapy Product
Table 90. Zahler Revenue in Allergy Non-pharmacologic Therapy Business (2019-2024) & (US$ Million)
Table 91. Zahler Recent Development
Table 92. VitaTree Company Detail
Table 93. VitaTree Business Overview
Table 94. VitaTree Allergy Non-pharmacologic Therapy Product
Table 95. VitaTree Revenue in Allergy Non-pharmacologic Therapy Business (2019-2024) & (US$ Million)
Table 96. VitaTree Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Allergy Non-pharmacologic Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Allergy Non-pharmacologic Therapy Market Share by Type: 2023 VS 2030
Figure 3. Capsule Features
Figure 4. Tablet Features
Figure 5. Liquid Features
Figure 6. Global Allergy Non-pharmacologic Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Allergy Non-pharmacologic Therapy Market Share by Application: 2023 VS 2030
Figure 8. Skin Allergy Case Studies
Figure 9. Pouen Allergy Case Studies
Figure 10. Dust Allergy Case Studies
Figure 11. Allergy Non-pharmacologic Therapy Report Years Considered
Figure 12. Global Allergy Non-pharmacologic Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Allergy Non-pharmacologic Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Allergy Non-pharmacologic Therapy Market Share by Region: 2023 VS 2030
Figure 15. Global Allergy Non-pharmacologic Therapy Market Share by Players in 2023
Figure 16. Global Top Allergy Non-pharmacologic Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergy Non-pharmacologic Therapy as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Allergy Non-pharmacologic Therapy Revenue in 2023
Figure 18. North America Allergy Non-pharmacologic Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Allergy Non-pharmacologic Therapy Market Share by Country (2019-2030)
Figure 20. United States Allergy Non-pharmacologic Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Allergy Non-pharmacologic Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Allergy Non-pharmacologic Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Allergy Non-pharmacologic Therapy Market Share by Country (2019-2030)
Figure 24. Germany Allergy Non-pharmacologic Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Allergy Non-pharmacologic Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Allergy Non-pharmacologic Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Allergy Non-pharmacologic Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Allergy Non-pharmacologic Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Allergy Non-pharmacologic Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Allergy Non-pharmacologic Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Allergy Non-pharmacologic Therapy Market Share by Region (2019-2030)
Figure 32. China Allergy Non-pharmacologic Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Allergy Non-pharmacologic Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Allergy Non-pharmacologic Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Allergy Non-pharmacologic Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Allergy Non-pharmacologic Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Allergy Non-pharmacologic Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Allergy Non-pharmacologic Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Allergy Non-pharmacologic Therapy Market Share by Country (2019-2030)
Figure 40. Mexico Allergy Non-pharmacologic Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Allergy Non-pharmacologic Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Allergy Non-pharmacologic Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Allergy Non-pharmacologic Therapy Market Share by Country (2019-2030)
Figure 44. Turkey Allergy Non-pharmacologic Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Allergy Non-pharmacologic Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Kirkland Revenue Growth Rate in Allergy Non-pharmacologic Therapy Business (2019-2024)
Figure 47. GNC Revenue Growth Rate in Allergy Non-pharmacologic Therapy Business (2019-2024)
Figure 48. Blackmores Revenue Growth Rate in Allergy Non-pharmacologic Therapy Business (2019-2024)
Figure 49. Thompson's Revenue Growth Rate in Allergy Non-pharmacologic Therapy Business (2019-2024)
Figure 50. BY-HEALTH Revenue Growth Rate in Allergy Non-pharmacologic Therapy Business (2019-2024)
Figure 51. Healthy Care Revenue Growth Rate in Allergy Non-pharmacologic Therapy Business (2019-2024)
Figure 52. Emerald Labs Revenue Growth Rate in Allergy Non-pharmacologic Therapy Business (2019-2024)
Figure 53. FANCL Corporation Revenue Growth Rate in Allergy Non-pharmacologic Therapy Business (2019-2024)
Figure 54. Zahler Revenue Growth Rate in Allergy Non-pharmacologic Therapy Business (2019-2024)
Figure 55. VitaTree Revenue Growth Rate in Allergy Non-pharmacologic Therapy Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
